The equine leptospirosis vaccine Lepto EQ Innovator is now approved for use in broodmares during the entire pregnancy, manufacturer Zoetis Inc. reported. “Leptospires can cause late-term abortion in mares,” said Jacquelin Boggs, DVM, MS, Dipl. ACVIM, a senior veterinarian in Zoetis’ equine technical services. “The expanded label claim allows the equine breeding community the flexibility to use Lepto EQ Innovator to fit their breeding program’s needs and help elevate antibody titer levels when most needed.”Jacquelin Boggs, DVM, MS, Dipl. ACVIM, a senior veterinarian in Zoetis’ equine technical services. “The expanded label claim allows the equine breeding community the flexibility to use Lepto EQ Innovator to fit their breeding program’s needs and help elevate antibody titer levels when most needed.” The vaccine was previously approved by the U.S. Department of Agriculture for use in horses 6 months or older and through the second trimester. The vaccine is the only one formulated to fight Leptospira interrogans serovar Pomona (L. Pomona). Thirteen percent of bacterial abortions are caused by L. pomona, the company stated. Zoetis also makes equine vaccines such as Fluvac Innovator and West Nile-Innovator. The company’s corporate headquarters moved in late September from Florham Park, N.J., to Parsippany, N.J. Originally published in the November 2016 issue of Veterinary Practice News. Did you enjoy this article? Then subscribe today!
